Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathologyResearch in context

Summary: Background: Blood-based biomarkers of Alzheimer’s disease (AD) have become increasingly important as scalable tools for diagnosis and determining clinical trial eligibility. P-tau217 is the most promising due to its excellent sensitivity and specificity for AD-related pathological changes....

Descripción completa

Detalles Bibliográficos

Autores principales:	Joseph Therriault, Nicholas James Ashton, Ilaria Pola, Gallen Triana-Baltzer, Wagner Scheeren Brum, Guglielmo Di Molfetta, Burak Arslan, Nesrine Rahmouni, Cecile Tissot, Stijn Servaes, Jenna Stevenson, Arthur Cassa Macedo, Tharick Ali Pascoal, Hartmuth Christian Kolb, Andreas Jeromin, Kaj Blennow, Henrik Zetterberg, Pedro Rosa-Neto, Andrea Lessa Benedet
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2024-04-01
Colección:	EBioMedicine
Materias:	Alzheimer’s disease Blood biomarker p-tau217 Comparison Diagnosis
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2352396424000811
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!